Management of Non-Hodgkin Lymphoma: ICMR Consensus Document.

about

Editorial: Indian Guidelines for Treatment of Pediatric Malignancies.

P2860

Q53430445-4B962DF8-45AA-4F27-888C-774F609677AF

P2860

Management of Non-Hodgkin Lymphoma: ICMR Consensus Document.

Item

http://www.wikidata.org/entity/Q38371659

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Management of Non-Hodgkin Lymphoma: ICMR Consensus Document.

@en

type

Item

label

Management of Non-Hodgkin Lymphoma: ICMR Consensus Document.

@en

prefLabel

Management of Non-Hodgkin Lymphoma: ICMR Consensus Document.

@en

P1476

Management of Non-Hodgkin Lymphoma: ICMR Consensus Document

@en

P2093

Brijesh Arora

http://www.w3.org/2001/XMLSchema#string

Deepak Bansal

http://www.w3.org/2001/XMLSchema#string

G K Rath

http://www.w3.org/2001/XMLSchema#string

Gauri Kapoor

http://www.w3.org/2001/XMLSchema#string

Girish Chinnaswamy

http://www.w3.org/2001/XMLSchema#string

Maya Prasad

http://www.w3.org/2001/XMLSchema#string

Nirav Thacker

http://www.w3.org/2001/XMLSchema#string

Rupinder Singh Dhaliwal

http://www.w3.org/2001/XMLSchema#string

Sameer Bakhshi

http://www.w3.org/2001/XMLSchema#string

Sandeep Agarwala

http://www.w3.org/2001/XMLSchema#string

P2860

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.

Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study.

Revised International Pediatric Non-Hodgkin Lymphoma Staging System.

Outcome and pathologic classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB/LMB96 mature B-NHL therapy

A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Epidemiology of childhood cancer in India.

Outcome of newly diagnosed children and adolescents with localized lymphoblastic lymphoma treated on Children's Oncology Group trial A5971: a report from the Children's Oncology Group.

Outcome of children with primary resistant or relapsed non-Hodgkin lymphoma and mature B-cell leukemia after intensive first-line treatment: a population-based analysis of the Austrian Cooperative Study Group.

Single-drug vinblastine as salvage treatment for refractory or relapsed anaplastic large-cell lymphoma: a report from the French Society of Pediatric Oncology.

Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine in the maintenance phase of the APO regimen: a Pediatric Oncology Group phase III tri

P2888

s12098-017-2318-0

P304

382-392

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12098-017-2318-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Venkatraman Radhakrishnan

P577

2017-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084513439

http://www.w3.org/2001/XMLSchema#string

P698

28378140

http://www.w3.org/2001/XMLSchema#string

Management of Non-Hodgkin Lymphoma: ICMR Consensus Document.

about

P2860

P2860

Management of Non-Hodgkin Lymphoma: ICMR Consensus Document.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698